A detailed history of Cubist Systematic Strategies, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 24,200 shares of TMDX stock, worth $1.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,200
Previous 30,900 21.68%
Holding current value
$1.67 Million
Previous $4.65 Million 18.37%
% of portfolio
0.02%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$70.86 - $89.93 $1.61 Million - $2.05 Million
-22,781 Reduced 86.96%
3,417 $252,000
Q4 2023

Feb 14, 2024

SELL
$36.74 - $81.08 $884,993 - $1.95 Million
-24,088 Reduced 47.9%
26,198 $2.07 Million
Q3 2023

Nov 14, 2023

SELL
$53.47 - $96.07 $493,260 - $886,245
-9,225 Reduced 15.5%
50,286 $2.75 Million
Q2 2023

Aug 14, 2023

BUY
$66.23 - $88.73 $84,840 - $113,663
1,281 Added 2.2%
59,511 $5 Million
Q1 2023

May 15, 2023

BUY
$53.63 - $82.33 $1.06 Million - $1.63 Million
19,836 Added 51.66%
58,230 $4.41 Million
Q4 2022

Feb 14, 2023

SELL
$39.08 - $64.29 $1.3 Million - $2.15 Million
-33,366 Reduced 46.5%
38,394 $2.37 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $1.65 Million - $2.91 Million
52,226 Added 267.36%
71,760 $3 Million
Q2 2022

Aug 15, 2022

BUY
$20.56 - $32.15 $401,619 - $628,018
19,534 New
19,534 $614,000
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $17,547 - $23,363
-677 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$21.63 - $40.07 $57,752 - $106,986
-2,670 Reduced 79.77%
677 $22,000
Q1 2021

May 17, 2021

BUY
$17.75 - $47.82 $57,385 - $154,602
3,233 Added 2835.96%
3,347 $139,000
Q4 2020

Feb 16, 2021

SELL
$11.91 - $19.9 $24,522 - $40,974
-2,059 Reduced 94.75%
114 $2,000
Q3 2020

Nov 16, 2020

BUY
$13.78 - $18.84 $29,943 - $40,939
2,173 New
2,173 $30,000
Q3 2019

Nov 14, 2019

SELL
$20.27 - $28.93 $219,888 - $313,832
-10,848 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.36 - $30.41 $242,561 - $329,887
10,848 New
10,848 $314,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.19B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.